SIRPα/CD172a Regulates Eosinophil Homeostasis
Open Access
- 1 September 2011
- journal article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 187 (5) , 2268-2277
Abstract
Eosinophils are abundant in the lamina propria of the small intestine, but they rarely show degranulation in situ under steady-state conditions. In this study, using two novel mAbs, we found that intestinal eosinophils constitutively expressed a high level of an inhibitory receptor signal regulatory protein α (SIRPα)/CD172a and a low, but significant, level of a tetraspanin CD63, whose upregulation is closely associated with degranulation. Cross-linking SIRPα/CD172a on the surface of wild-type eosinophils significantly inhibited the release of eosinophil peroxidase induced by the calcium ionophore A23187, whereas this cross-linking effect was not observed in eosinophils isolated from mice expressing a mutated SIRPα/CD172a that lacks most of its cytoplasmic domain (SIRPα Cyto−/−). The SIRPα Cyto−/− eosinophils showed reduced viability, increased CD63 expression, and increased eosinophil peroxidase release with or without A23187 stimulation in vitro. In addition, SIRPα Cyto−/− mice showed increased frequencies of Annexin V-binding eosinophils and free MBP+CD63+ extracellular granules, as well as increased tissue remodeling in the small intestine under steady-state conditions. Mice deficient in CD47, which is a ligand for SIRPα/CD172a, recapitulated these phenomena. Moreover, during Th2-biased inflammation, increased eosinophil cell death and degranulation were obvious in a number of tissues, including the small intestine, in the SIRPα Cyto−/− mice compared with wild-type mice. Collectively, our results indicated that SIRPα/CD172a regulates eosinophil homeostasis, probably by interacting with CD47, with substantial effects on eosinophil survival. Thus, SIRPα/CD172a is a potential therapeutic target for eosinophil-associated diseases.Keywords
This publication has 55 references indexed in Scilit:
- Regulation by SIRPα of dendritic cell homeostasis in lymphoid tissuesBlood, 2010
- Mouse and Human Eosinophils Degranulate in Response to Platelet-Activating Factor (PAF) and LysoPAF via a PAF-Receptor–Independent Mechanism: Evidence for a Novel ReceptorThe Journal of Immunology, 2010
- Nuocytes represent a new innate effector leukocyte that mediates type-2 immunityNature, 2010
- Functional extracellular eosinophil granules: novel implications in eosinophil immunobiologyCurrent Opinion in Immunology, 2009
- Eosinophil granules function extracellularly as receptor-mediated secretory organellesProceedings of the National Academy of Sciences, 2008
- A dual activation and inhibition role for the paired immunoglobulin-like receptor B in eosinophilsBlood, 2008
- Origin, regulation and physiological function of intestinal oeosinophilsBest Practice & Research Clinical Gastroenterology, 2008
- Defining the in vivo function of Siglec-F, a CD33-related Siglec expressed on mouse eosinophilsBlood, 2007
- Type 2 immunity is controlled by IL-4/IL-13 expression in hematopoietic non-eosinophil cells of the innate immune systemJournal of Experimental Medicine, 2006
- The murine inhibitory receptor mSiglec‐E is expressed broadly on cells of the innate immune system whereas mSiglec‐F is restricted to eosinophilsEuropean Journal of Immunology, 2004